The FDA is considering approving a groundbreaking new treatment that uses gene editing to potentially cure sickle cell disease, offering hope for those suffering from the painful and deadly disease.
The post FDA considers first CRISPR gene editing treatment that may cure sickle cell appeared first on Dallas Examiner.
